Якість даних

• Покриття біомаркерів: 0/0 відомо (100%), 0 відсутньо, 0 прогалин default-треку
• Неоцінені RedFlags: RF-A1AT-DEFICIENCY-HCC-LUNG-PREVENTION, RF-AAIPI-HIGH, RF-ACHALASIA-ESOPHAGEAL-PREVENTION, RF-ACTIVE-AUTOIMMUNE-DISEASE-ICI-RISK, RF-ADVSM-KIT-D816V, RF-AGGRESSIVE-HISTOLOGY-TRANSFORMATION, RF-AITL-AUTOIMMUNE-CYTOPENIA, RF-AITL-EBV-DRIVEN-B-CELL, RF-AITL-FRAILTY-AGE, RF-AITL-HYPOGAMMA, RF-AITL-ORGAN-DYSFUNCTION, RF-AITL-ROMIDEPSIN-INELIGIBLE, RF-AITL-TRANSFORMATION-PROGRESSION, RF-ALCL-FRAILTY-AGE, RF-ALCL-INFECTION-SCREENING, RF-ALCL-ORGAN-DYSFUNCTION, RF-ALCL-TRANSFORMATION-PROGRESSION, RF-AML-CD33-POS-GO-CANDIDATE, RF-AML-CORE-BINDING-FACTOR-FAVORABLE, RF-AML-EMERGENCY-TLS-LEUKOSTASIS, RF-AML-FLT3-ACTIONABLE, RF-AML-FRAILTY-AGE, RF-AML-HIGH-RISK-BIOLOGY, RF-AML-IDH1-MUT-ACTIONABLE, RF-AML-IDH2-MUT-ACTIONABLE, RF-AML-INFECTION-SCREENING, RF-AML-KMT2A-ACTIONABLE, RF-AML-MEASURABLE-RESIDUAL-DISEASE, RF-AML-NPM1-MUT-FAVORABLE, RF-AML-ORGAN-DYSFUNCTION, RF-AML-SECONDARY-AML-MRC-CPX351-ELIGIBLE, RF-AML-TP53-ADVERSE, RF-AML-TRANSFORMATION-PROGRESSION, RF-APL-EMERGENCY-DIC, RF-APL-FRAILTY-AGE, RF-APL-HIGH-RISK-BIOLOGY, RF-APL-INFECTION-SCREENING, RF-APL-ORGAN-DYSFUNCTION, RF-APL-TRANSFORMATION-PROGRESSION, RF-ASCT-ELIGIBLE-COMPOSITE, RF-ATC-BRAF-V600E-ACTIONABLE, RF-ATLL-HIGH-RISK-BIOLOGY, RF-ATLL-HYPERCALCEMIA, RF-ATLL-INFECTION-SCREENING, RF-ATLL-ORGAN-DYSFUNCTION, RF-ATLL-SHIMOYAMA-INDOLENT, RF-ATLL-TRANSFORMATION-PROGRESSION, RF-AUTOIMMUNE-THYROIDITIS-LYMPHOMA-PREVENTION, RF-B-ALL-CNS-LEUKEMIA, RF-B-ALL-EMERGENCY-TLS-LEUKOSTASIS, RF-B-ALL-FRAILTY-AGE, RF-B-ALL-HIGH-RISK-BIOLOGY, RF-B-ALL-INFECTION-SCREENING, RF-B-ALL-ORGAN-DYSFUNCTION, RF-B-ALL-TRANSFORMATION-PROGRESSION, RF-BALL-CD22-POS-INO-CANDIDATE, RF-BAP1-CONFIRMED-CARRIER, RF-BAP1-FAMILY-HISTORY-SUSPICION, RF-BARRETTS-ESOPHAGUS-PREVENTION, RF-BINET-A, RF-BINET-B-C, RF-BRCA-CONFIRMED-CARRIER, RF-BRCA-HBOC-FAMILY-HISTORY-SUSPICION, RF-BREAST-AKT1-E17K-ACTIONABLE, RF-BREAST-AKT1-E17K-CAPIVASERTIB-CANDIDATE, RF-BREAST-BRCA-GERMLINE-ACTIONABLE, RF-BREAST-CDH1-LOBULAR-CANDIDATE, RF-BREAST-EARLY-STAGE, RF-BREAST-ESR1-MUT-ACTIONABLE, RF-BREAST-ESR1-Y537S-D538G-CANDIDATE, RF-BREAST-FRAILTY-AGE, RF-BREAST-HER2-AMP-ACTIONABLE, RF-BREAST-HER2-LOW-ACTIONABLE, RF-BREAST-HER2-ULTRALOW-CANDIDATE, RF-BREAST-HIGH-RISK-BIOLOGY, RF-BREAST-INFECTION-SCREENING, RF-BREAST-ORGAN-DYSFUNCTION, RF-BREAST-OVARIAN-HRD-ASSAY-DISTINCTION, RF-BREAST-PIK3CA-COALT-INAVOLISIB-CANDIDATE, RF-BREAST-PIK3CA-MUT-ACTIONABLE, RF-BREAST-STAGE-IV-METASTATIC, RF-BREAST-TNBC, RF-BREAST-TRANSFORMATION-PROGRESSION, RF-BULKY-DISEASE, RF-BURKITT-EMERGENCY-TLS, RF-BURKITT-FRAILTY-AGE, RF-BURKITT-HIGH-RISK, RF-BURKITT-IFOS-CONTRAINDICATED, RF-BURKITT-INFECTION-SCREENING, RF-BURKITT-ORGAN-DYSFUNCTION, RF-BURKITT-TRANSFORMATION-PROGRESSION, RF-CAR-T-ELIGIBLE, RF-CAR-T-INELIGIBLE-AGE-COMORBID, RF-CAR-T-INELIGIBLE-ORGAN, RF-CELIAC-REFRACTORY-EATL-PREVENTION, RF-CERVICAL-FRAILTY-AGE, RF-CERVICAL-HIGH-RISK-BIOLOGY, RF-CERVICAL-HYDRONEPHROSIS-PELVIC-OBSTRUCTION, RF-CERVICAL-INFECTION-SCREENING, RF-CERVICAL-PDL1-CPS-1-PLUS, RF-CERVICAL-TRANSFORMATION-PROGRESSION, RF-CHAARTED-HIGH-VOLUME-MHSPC, RF-CHL-ADVANCED-STAGE, RF-CHL-FRAILTY-AGE, RF-CHL-INFECTION-SCREENING, RF-CHL-ORGAN-DYSFUNCTION, RF-CHL-TRANSFORMATION-PROGRESSION, RF-CHOLANGIO-FGFR2-FUSION-ACTIONABLE, RF-CHOLANGIO-IDH1-R132-ACTIONABLE, RF-CHOLANGIOCARCINOMA-FRAILTY-AGE, RF-CHOLANGIOCARCINOMA-HIGH-RISK-BIOLOGY, RF-CHOLANGIOCARCINOMA-INFECTION-SCREENING, RF-CHOLANGIOCARCINOMA-ORGAN-DYSFUNCTION, RF-CHOLANGIOCARCINOMA-TRANSFORMATION-PROGRESSION, RF-CHONDROSARCOMA-FRAILTY-AGE, RF-CHONDROSARCOMA-HIGH-RISK-BIOLOGY, RF-CHONDROSARCOMA-INFECTION-SCREENING, RF-CHONDROSARCOMA-ORGAN-DYSFUNCTION, RF-CHONDROSARCOMA-TRANSFORMATION-PROGRESSION, RF-CHRONIC-ATROPHIC-GASTRITIS-PREVENTION, RF-CHRONIC-EBV-MALIGNANCY-PREVENTION, RF-CHRONIC-H-PYLORI-MALIGNANCY-PREVENTION, RF-CHRONIC-HBV-MALIGNANCY-PREVENTION, RF-CHRONIC-HCV-HBV-COINFECTION-PREVENTION, RF-CHRONIC-HCV-NHL-PREVENTION-OPPORTUNITY, RF-CHRONIC-HHV8-MALIGNANCY-PREVENTION, RF-CHRONIC-HIV-HBV-COINFECTION-PREVENTION, RF-CHRONIC-HIV-MALIGNANCY-PREVENTION, RF-CHRONIC-HPV-MALIGNANCY-PREVENTION, RF-CHRONIC-HTLV-1-MALIGNANCY-PREVENTION, RF-CHRONIC-PANCREATITIS-PDAC-PREVENTION, RF-CLL-FRAILTY-AGE, RF-CLL-HIGH-RISK, RF-CLL-INFECTION-SCREENING, RF-CLL-ORGAN-DYSFUNCTION, RF-CLL-POST-BTKI-C481-ACTIONABLE, RF-CLL-TP53-DELETION-ACTIONABLE, RF-CLL-TRANSFORMATION-PROGRESSION, RF-CLL-VEN-RESISTANT-ACTIONABLE, RF-CLONORCHIS-CHOLANGIO-PREVENTION, RF-CML-COMORBIDITY-COMPLEX, RF-CML-FRAILTY-AGE, RF-CML-HIGH-RISK-ELTS, RF-CML-INFECTION-SCREENING, RF-CML-ORGAN-DYSFUNCTION, RF-CML-T315I-MUTATION, RF-CML-TRANSFORMATION-PROGRESSION, RF-CNS-METASTASES-ACTIVE, RF-COWDEN-CONFIRMED-CARRIER, RF-COWDEN-FAMILY-HISTORY-SUSPICION, RF-CRC-BRAF-V600E-POOR-PROGNOSIS, RF-CRC-EMERGENCY-OBSTRUCTION-PERFORATION, RF-CRC-FRAILTY-AGE, RF-CRC-HER2-AMP-ACTIONABLE, RF-CRC-INFECTION-SCREENING, RF-CRC-MSI-H-ACTIONABILITY, RF-CRC-OLIGOMET-LIVER-DEFINITION, RF-CRC-RAS-MUTANT, RF-CRC-RAS-WT, RF-CRC-TRANSFORMATION-PROGRESSION, RF-DECOMP-CIRRHOSIS, RF-DIPSS-PLUS-HIGH, RF-DLBCL-CART-INELIGIBLE-POST-2L, RF-DLBCL-CD20-POS-EPCORITAMAB-CANDIDATE, RF-DLBCL-CD20-POS-GLOFITAMAB-CANDIDATE, RF-DLBCL-CD79B-MUT-MCD-CANDIDATE, RF-DLBCL-CNS-RISK, RF-DLBCL-FRAILTY-AGE, RF-DLBCL-HIGH-IPI, RF-DLBCL-HIGH-RISK-BIOLOGY, RF-DLBCL-INFECTION-SCREENING, RF-DLBCL-ORGAN-DYSFUNCTION, RF-DLBCL-TRANSFORMATION-PROGRESSION, RF-EATL-HIGH-RISK-BIOLOGY, RF-EATL-INFECTION-SCREENING, RF-EATL-ORGAN-DYSFUNCTION, RF-EATL-TRANSFORMATION-PROGRESSION, RF-ENDOMETRIAL-FIT-FOR-LENVATINIB-COMBO, RF-ENDOMETRIAL-FRAILTY-AGE, RF-ENDOMETRIAL-HIGH-RISK-BIOLOGY, RF-ENDOMETRIAL-INFECTION-SCREENING, RF-ENDOMETRIAL-ORGAN-DYSFUNCTION, RF-ENDOMETRIAL-TRANSFORMATION-PROGRESSION, RF-ENVIRONMENTAL-AIR-POLLUTION-LUNG-PREVENTION, RF-ENVIRONMENTAL-ARSENIC-WATER-PREVENTION, RF-ENVIRONMENTAL-OUTDOOR-UV-SKIN-PREVENTION, RF-ENVIRONMENTAL-SECONDHAND-SMOKE-LUNG-PREVENTION, RF-ESOPH-FRAILTY-AGE, RF-ESOPH-HIGH-RISK-BIOLOGY, RF-ESOPH-INFECTION-SCREENING, RF-ESOPH-SEVERE-DYSPHAGIA-ASPIRATION, RF-ESOPH-TRANSFORMATION-PROGRESSION, RF-ESOPHAGEAL-POST-CROSS-NON-PCR, RF-ET-HU-RESISTANT-INTOLERANT, RF-ET-TRANSFORMATION-PROGRESSION, RF-FAMMM-CONFIRMED-CARRIER, RF-FAMMM-FAMILY-HISTORY-SUSPICION, RF-FAP-CONFIRMED-CARRIER, RF-FAP-FAMILY-HISTORY-SUSPICION, RF-FL-EZH2-Y641-ACTIONABLE, RF-FL-FRAILTY-AGE, RF-FL-HIGH-TUMOR-BURDEN-GELF, RF-FL-INFECTION-SCREENING, RF-FL-ORGAN-DYSFUNCTION, RF-FL-TRANSFORMATION-SUSPECT, RF-FOLLICULAR-TRANSFORMATION, RF-FRAILTY-AGE-G8-LOW, RF-GASTRIC-CLDN18-2-ACTIONABLE, RF-GASTRIC-EMERGENCY-BLEED-OBSTRUCTION, RF-GASTRIC-FRAILTY-AGE, RF-GASTRIC-HIGH-RISK-BIOLOGY, RF-GASTRIC-INFECTION-SCREENING, RF-GASTRIC-PDL1-CPS-1-PLUS, RF-GASTRIC-TRANSFORMATION-PROGRESSION, RF-GBM-FRAILTY-AGE, RF-GBM-HIGH-RISK-BIOLOGY, RF-GBM-INFECTION-SCREENING, RF-GBM-INTRACRANIAL-PRESSURE-EMERGENCY, RF-GBM-TRANSFORMATION-PROGRESSION, RF-GELF-CRITERIA-MET, RF-GELF-LOW-BURDEN, RF-GIST-FRAILTY-AGE, RF-GIST-HIGH-RISK-BIOLOGY, RF-GIST-INFECTION-SCREENING, RF-GIST-ORGAN-DYSFUNCTION, RF-GIST-PDGFRA-D842V, RF-GIST-TRANSFORMATION-PROGRESSION, RF-GLIOMA-LOW-GRADE-FRAILTY-AGE, RF-GLIOMA-LOW-GRADE-HIGH-RISK-BIOLOGY, RF-GLIOMA-LOW-GRADE-INFECTION-SCREENING, RF-GLIOMA-LOW-GRADE-INTRACRANIAL-PRESSURE, RF-GLIOMA-LOW-GRADE-ORGAN-DYSFUNCTION, RF-GLIOMA-LOW-GRADE-TRANSFORMATION-PROGRESSION, RF-HASFORD-HIGH, RF-HBV-COINFECTION, RF-HCC-AFP-RAPID-RISE, RF-HCC-CHILD-PUGH-B-C, RF-HCC-FRAILTY-AGE, RF-HCC-HBV-REACTIVATION-RISK, RF-HCC-HIGH-RISK-BIOLOGY, RF-HCC-VARICEAL-BLEED, RF-HCL-FRAILTY-AGE, RF-HCL-HIGH-RISK-BIOLOGY, RF-HCL-INFECTION-SCREENING, RF-HCL-ORGAN-DYSFUNCTION, RF-HCL-TRANSFORMATION-PROGRESSION, RF-HCV-MZL-FRAILTY-AGE, RF-HEMOCHROMATOSIS-HCC-PREVENTION, RF-HGBL-DH-CNS-PROPHYLAXIS-TRIGGER, RF-HGBL-DH-EMERGENCY-TLS, RF-HGBL-DH-HIGH-RISK-BIOLOGY, RF-HGBL-DH-INFECTION-SCREENING, RF-HGBL-DH-ORGAN-DYSFUNCTION, RF-HGBL-DH-TRANSFORMATION-PROGRESSION, RF-HLRCC-CONFIRMED-CARRIER, RF-HLRCC-FAMILY-HISTORY-SUSPICION, RF-HNSCC-FRAILTY-AGE, RF-HNSCC-HIGH-RISK-BIOLOGY, RF-HNSCC-INFECTION-SCREENING, RF-HNSCC-ORGAN-DYSFUNCTION, RF-HNSCC-TRANSFORMATION-PROGRESSION, RF-HPRC-CONFIRMED-CARRIER, RF-HPRC-FAMILY-HISTORY-SUSPICION, RF-HSTCL-HIGH-RISK-BIOLOGY, RF-HSTCL-INFECTION-SCREENING, RF-HSTCL-ORGAN-DYSFUNCTION, RF-HSTCL-TRANSFORMATION-PROGRESSION, RF-IATROGENIC-ALKYLATOR-TAML-PREVENTION, RF-IATROGENIC-ANTHRACYCLINE-CARDIO-PREVENTION, RF-IATROGENIC-ANTHRACYCLINE-LATE-CARDIO-PREVENTION, RF-IATROGENIC-ANTI-TNF-LYMPHOMA-PREVENTION, RF-IATROGENIC-AZATHIOPRINE-LONGTERM-PREVENTION, RF-IATROGENIC-BLEOMYCIN-LATE-PREVENTION, RF-IATROGENIC-CALCINEURIN-INHIBITOR-LONGTERM-PREVENTION, RF-IATROGENIC-COMBINED-HRT-PREVENTION, RF-IATROGENIC-CRANIAL-RT-LATE-PREVENTION, RF-IATROGENIC-CYCLOPHOSPHAMIDE-LATE-PREVENTION, RF-IATROGENIC-DES-EXPOSURE-PREVENTION, RF-IATROGENIC-LONG-TERM-HRMNL-CONTRACEPTION-PREVENTION, RF-IATROGENIC-LONG-TERM-PPI-GASTRIC-NET-PREVENTION, RF-IATROGENIC-PEDIATRIC-PELVIC-RT-PREVENTION, RF-IATROGENIC-PLATINUM-LATE-PREVENTION, RF-IATROGENIC-PRIOR-RADIATION-PREVENTION, RF-IATROGENIC-TAMOXIFEN-ENDOMETRIAL-PREVENTION, RF-IATROGENIC-TOPO2-TAML-PREVENTION, RF-IATROGENIC-TRANSPLANT-IMMUNOSUPPRESSION-LONGTERM-PREVENTION, RF-IATROGENIC-TRANSPLANT-IMMUNOSUPPRESSION-PREVENTION, RF-IBD-CRC-PREVENTION, RF-IFS-FRAILTY-AGE, RF-IFS-HIGH-RISK-BIOLOGY, RF-IFS-INFECTION-SCREENING, RF-IFS-ORGAN-DYSFUNCTION, RF-IFS-TRANSFORMATION-PROGRESSION, RF-IMT-FRAILTY-AGE, RF-IMT-HIGH-RISK-BIOLOGY, RF-IMT-INFECTION-SCREENING, RF-IMT-ORGAN-DYSFUNCTION, RF-IMT-TRANSFORMATION-PROGRESSION, RF-IPI-HIGH, RF-IPI-INTERMEDIATE, RF-IPI-LOW, RF-IPSS-M-HIGH, RF-IPSS-R-VERY-HIGH, RF-ISS-1, RF-ISS-3, RF-LACTATION-ACTIVE, RF-LATITUDE-HIGH-RISK-MHSPC, RF-LEPTOMENINGEAL-DISEASE, RF-LI-FRAUMENI-CONFIRMED-CARRIER, RF-LI-FRAUMENI-FAMILY-HISTORY-SUSPICION, RF-LIFESTYLE-ALCOHOL-CANCER-PREVENTION, RF-LIFESTYLE-HIGH-RED-MEAT-CRC-PREVENTION, RF-LIFESTYLE-HOT-BEVERAGES-PREVENTION, RF-LIFESTYLE-LOW-CALCIUM-VIT-D-CRC-PREVENTION, RF-LIFESTYLE-LOW-FIBER-CRC-PREVENTION, RF-LIFESTYLE-LOW-MEDITERRANEAN-DIET-PREVENTION, RF-LIFESTYLE-OBESITY-CANCER-PREVENTION, RF-LIFESTYLE-PROCESSED-MEAT-PREVENTION, RF-LIFESTYLE-SEDENTARY-PREVENTION, RF-LIFESTYLE-TOBACCO-CANCER-PREVENTION, RF-LIFESTYLE-UV-EXPOSURE-PREVENTION, RF-LYNCH-CONFIRMED-CARRIER, RF-LYNCH-FAMILY-HISTORY-SUSPICION, RF-MASTOCYTOSIS-FRAILTY-AGE, RF-MASTOCYTOSIS-HIGH-RISK-BIOLOGY, RF-MASTOCYTOSIS-INFECTION-SCREENING, RF-MASTOCYTOSIS-ORGAN-DYSFUNCTION, RF-MASTOCYTOSIS-TRANSFORMATION-PROGRESSION, RF-MCL-BLASTOID-OR-TP53, RF-MCL-BLASTOID-VARIANT, RF-MCL-FRAILTY-AGE, RF-MCL-INFECTION-SCREENING, RF-MCL-ORGAN-DYSFUNCTION, RF-MCL-POST-BTKI-C481-ACTIONABLE, RF-MCL-TRANSFORMATION-PROGRESSION, RF-MDS-DEL-5Q-ISOLATED, RF-MDS-FRAILTY-AGE, RF-MDS-HIGH-RISK-IPSS, RF-MDS-INFECTION-SCREENING, RF-MDS-ORGAN-DYSFUNCTION, RF-MDS-TP53-MUTATION, RF-MDS-TRANSFORMATION-PROGRESSION, RF-MDS-TRANSPLANT-ELIGIBLE, RF-MELANOMA-BRAF-V600-ACTIONABLE, RF-MELANOMA-HIGH-RISK-BIOLOGY, RF-MELANOMA-INFECTION-SCREENING, RF-MELANOMA-IO-RESISTANT, RF-MELANOMA-KIT-MUT-ACTIONABLE, RF-MELANOMA-NF1-MUT-CANDIDATE, RF-MELANOMA-ORGAN-DYSFUNCTION, RF-MELANOMA-STAGE-III-RESECTED, RF-MELANOMA-TRANSFORMATION-PROGRESSION, RF-MEN1-CONFIRMED-CARRIER, RF-MEN1-FAMILY-HISTORY-SUSPICION, RF-MEN2-CONFIRMED-CARRIER, RF-MEN2-FAMILY-HISTORY-SUSPICION, RF-MF-LARGE-CELL-TRANSFORMATION, RF-MF-SEZARY-FRAILTY-AGE, RF-MF-SEZARY-INFECTION-SCREENING, RF-MF-SEZARY-LEUKEMIC, RF-MF-SEZARY-ORGAN-DYSFUNCTION, RF-MIPI-HIGH, RF-MIPI-LOW, RF-MM-BCMA-EXPRESSION-POS, RF-MM-CD38-EXPRESSION-DARA-CANDIDATE, RF-MM-CORD-COMPRESSION, RF-MM-FRAILTY-AGE, RF-MM-HIGH-RISK-CYTOGENETICS, RF-MM-HYPERCALCEMIA, RF-MM-HYPERVISCOSITY, RF-MM-INFECTION-SCREENING, RF-MM-RENAL-DYSFUNCTION, RF-MM-T11-14-ACTIONABLE, RF-MM-TRANSFORMATION-PROGRESSION, RF-MPN-SECONDARY-LEUKEMIA-PREVENTION, RF-MPNST-ADVANCED-DOXORUBICIN-UNSUITABLE, RF-MPNST-FRAILTY-AGE, RF-MPNST-HIGH-RISK-BIOLOGY, RF-MPNST-INFECTION-SCREENING, RF-MPNST-ORGAN-DYSFUNCTION, RF-MPNST-TRANSFORMATION-PROGRESSION, RF-MTC-FRAILTY-AGE, RF-MTC-HIGH-RISK-BIOLOGY, RF-MTC-INFECTION-SCREENING, RF-MTC-ORGAN-DYSFUNCTION, RF-MTC-RET-MUTANT, RF-MTC-TRANSFORMATION-PROGRESSION, RF-NET-CARCINOID-SYNDROME, RF-NET-HIGH-GRADE-G3, RF-NK-T-NASAL-HIGH-RISK-BIOLOGY, RF-NK-T-NASAL-INFECTION-SCREENING, RF-NK-T-NASAL-ORGAN-DYSFUNCTION, RF-NK-T-NASAL-TRANSFORMATION-PROGRESSION, RF-NLPBL-FRAILTY-AGE, RF-NLPBL-HIGH-RISK-BIOLOGY, RF-NLPBL-INFECTION-SCREENING, RF-NLPBL-ORGAN-DYSFUNCTION, RF-NLPBL-RT-CONTRAINDICATED, RF-NLPBL-TRANSFORMATION-PROGRESSION, RF-NMZL-FRAILTY-AGE, RF-NMZL-HIGH-RISK-BIOLOGY, RF-NMZL-INFECTION-SCREENING, RF-NMZL-ORGAN-DYSFUNCTION, RF-NMZL-TRANSFORMATION-PROGRESSION, RF-NSCLC-ALK-FUSION-ACTIONABLE, RF-NSCLC-BRAF-V600E-ACTIONABLE, RF-NSCLC-BRAIN-METS-EMERGENCY, RF-NSCLC-CORD-COMPRESSION, RF-NSCLC-EGFR-C797S-RESISTANCE, RF-NSCLC-EGFR-EX19DEL-ACTIONABLE, RF-NSCLC-EGFR-EX20INS-ACTIONABLE, RF-NSCLC-EGFR-T790M-ACTIONABLE, RF-NSCLC-FRAILTY-AGE, RF-NSCLC-HER2-MUT-ACTIONABLE, RF-NSCLC-HER3-HIGH-PATRITUMAB-CANDIDATE, RF-NSCLC-HIGH-RISK-BIOLOGY, RF-NSCLC-INFECTION-SCREENING, RF-NSCLC-KRAS-G12C-ACTIONABLE, RF-NSCLC-MALIGNANT-EFFUSION, RF-NSCLC-MET-AMP-ACTIONABLE, RF-NSCLC-MET-EX14-ACTIONABLE, RF-NSCLC-NRG1-FUSION-ZENO-CANDIDATE, RF-NSCLC-NTRK-FUSION-ACTIONABLE, RF-NSCLC-ORGAN-DYSFUNCTION, RF-NSCLC-PDL1-50-PLUS, RF-NSCLC-RET-FUSION-ACTIONABLE, RF-NSCLC-ROS1-FUSION-ACTIONABLE, RF-NSCLC-SVC-SYNDROME, RF-NSCLC-TRANSFORMATION-PROGRESSION, RF-NSCLC-TROP2-DATO-CANDIDATE, RF-OBLIGATE-CARDIO-TOXIC-NAIVE, RF-OCC-AROMATIC-AMINES-MALIGNANCY-PREVENTION, RF-OCC-ASBESTOS-MALIGNANCY-PREVENTION, RF-OCC-BENZENE-MALIGNANCY-PREVENTION, RF-OCC-DIESEL-EXHAUST-PREVENTION, RF-OCC-FIREFIGHTER-PREVENTION, RF-OCC-FORMALDEHYDE-PREVENTION, RF-OCC-IONIZING-RADIATION-PREVENTION, RF-OCC-PAH-PREVENTION, RF-OCC-PAINTERS-PREVENTION, RF-OCC-SILICA-PREVENTION, RF-OCC-VINYL-CHLORIDE-MALIGNANCY-PREVENTION, RF-OCC-WOOD-LEATHER-DUST-PREVENTION, RF-OLIGOMET-DEFINITION, RF-ONCOLOGIC-EMERGENCY-CORD-COMPRESSION, RF-ONCOLOGIC-EMERGENCY-SVC, RF-ONCOLOGIC-EMERGENCY-TLS, RF-OPISTHORCHIS-CHOLANGIO-PREVENTION, RF-ORGAN-CARDIAC-LVEF-LOW, RF-ORGAN-HEPATIC-CHILD-PUGH-B, RF-ORGAN-HEPATIC-CHILD-PUGH-C, RF-ORGAN-PULMONARY-DLCO-LOW, RF-ORGAN-RENAL-IMPAIRED, RF-OVARIAN-BRCA-MUT-ACTIONABLE, RF-OVARIAN-FRA-HIGH-ACTIONABLE, RF-OVARIAN-FRAILTY-AGE, RF-OVARIAN-HRD-ACTIONABILITY, RF-OVARIAN-HRD-POSITIVE-ACTIONABLE, RF-OVARIAN-INFECTION-SCREENING, RF-OVARIAN-PERIOPERATIVE-VTE, RF-OVARIAN-PLATINUM-RESISTANT, RF-OVARIAN-PLATINUM-SENSITIVE, RF-OVARIAN-SUBOPTIMAL-DEBULKING, RF-OVARIAN-TRANSFORMATION-PROGRESSION, RF-PAN-ATM-CHEK2-CDK12-PARPI-CANDIDATE, RF-PAN-BRCA-SOMATIC-PARPI-CANDIDATE, RF-PAN-CTDNA-MRD-POSITIVE, RF-PAN-PALB2-PARPI-CANDIDATE, RF-PAN-PDL1-CLONE-22C3-PEMBRO-ELIGIBLE, RF-PCNSL-FRAILTY-AGE, RF-PCNSL-HIGH-RISK-BIOLOGY, RF-PCNSL-INFECTION-SCREENING, RF-PCNSL-INTRACRANIAL-PRESSURE, RF-PCNSL-ORGAN-DYSFUNCTION, RF-PCNSL-TRANSFORMATION-PROGRESSION, RF-PDAC-BILIARY-OBSTRUCTION-CHOLANGITIS, RF-PDAC-FIT-FOR-FOLFIRINOX, RF-PDAC-FRAILTY-AGE, RF-PDAC-HIGH-RISK-BIOLOGY, RF-PDAC-INFECTION-SCREENING, RF-PDAC-TRANSFORMATION-PROGRESSION, RF-PEUTZ-JEGHERS-CONFIRMED-CARRIER, RF-PEUTZ-JEGHERS-FAMILY-HISTORY-SUSPICION, RF-PMBCL-FRAILTY-AGE, RF-PMBCL-HIGH-RISK-BIOLOGY, RF-PMBCL-INFECTION-SCREENING, RF-PMBCL-MEDIASTINAL-AIRWAY, RF-PMBCL-ORGAN-DYSFUNCTION, RF-PMBCL-SVC-SYNDROME, RF-PMBCL-TRANSFORMATION-PROGRESSION, RF-PMF-ANEMIA-DOMINANT, RF-PMF-BLAST-PROGRESSION, RF-PMF-FRAILTY-AGE, RF-PMF-HIGH-RISK-DIPSS, RF-PMF-INFECTION-SCREENING, RF-PMF-ORGAN-DYSFUNCTION, RF-POLE-POLD1-ENDOMETRIAL-LOW-RISK, RF-PREGNANCY-ACTIVE, RF-PREGNANCY-PLANNING, RF-PRIOR-BRAFI-MEKI-FAILED, RF-PRIOR-BTKI-PROGRESSION, RF-PRIOR-BV-NAIVE, RF-PRIOR-CDK46I-PROGRESSION, RF-PRIOR-EGFRI-PROGRESSION, RF-PRIOR-HDACI-NAIVE, RF-PRIOR-IO-PROGRESSION, RF-PRIOR-PARPI-EXPOSED, RF-PRIOR-PLATINUM-RESISTANT, RF-PROSTATE-AR-AMP-ARSI-RESISTANCE, RF-PROSTATE-AR-V7-ARSI-RESISTANCE, RF-PROSTATE-CORD-COMPRESSION, RF-PROSTATE-FRAILTY-AGE, RF-PROSTATE-HIGH-RISK-BIOLOGY, RF-PROSTATE-INFECTION-SCREENING, RF-PROSTATE-ORGAN-DYSFUNCTION, RF-PROSTATE-PSA-PROGRESSION, RF-PROSTATE-TMPRSS2-ERG-PROGNOSTIC, RF-PROSTATE-TRANSFORMATION-PROGRESSION, RF-PSC-CHOLANGIOCARCINOMA-PREVENTION, RF-PTCL-NOS-FRAILTY-AGE, RF-PTCL-NOS-INFECTION-SCREENING, RF-PTCL-NOS-ORGAN-DYSFUNCTION, RF-PTCL-NOS-TRANSFORMATION-PROGRESSION, RF-PTLD-FRAILTY-AGE, RF-PTLD-HIGH-RISK-BIOLOGY, RF-PTLD-INFECTION-SCREENING, RF-PTLD-ORGAN-DYSFUNCTION, RF-PTLD-TRANSFORMATION-PROGRESSION, RF-PV-ET-FRAILTY-AGE, RF-PV-ET-HIGH-THROMBOSIS-RISK, RF-PV-ET-INFECTION-SCREENING, RF-PV-ET-ORGAN-DYSFUNCTION, RF-PV-ET-PREGNANCY-OR-PLANNING, RF-PV-HU-RESISTANCE-INTOLERANCE, RF-R-ISS-3-HIGH-RISK, RF-RADON-MALIGNANCY-PREVENTION, RF-RAI-HIGH, RF-RAI-LOW, RF-RCC-FRAILTY-AGE, RF-RCC-HIGH-RISK-BIOLOGY, RF-RCC-IMDC-INTERMEDIATE-POOR-RISK, RF-RCC-INFECTION-SCREENING, RF-RCC-ORGAN-DYSFUNCTION, RF-RCC-TRANSFORMATION-PROGRESSION, RF-REPRODUCTIVE-BREAST-ENDOMETRIAL-PREVENTION, RF-REPRODUCTIVE-LATE-FIRST-PREGNANCY-PREVENTION, RF-REPRODUCTIVE-OCP-LONG-TERM, RF-RICHTER-TRANSFORMATION, RF-SALIVARY-ADVANCED-PALLIATIVE, RF-SALIVARY-FRAILTY-AGE, RF-SALIVARY-HIGH-RISK-BIOLOGY, RF-SALIVARY-INFECTION-SCREENING, RF-SALIVARY-ORGAN-DYSFUNCTION, RF-SALIVARY-TRANSFORMATION-PROGRESSION, RF-SANZ-HIGH-RISK, RF-SANZ-INTERMEDIATE, RF-SANZ-LOW-RISK, RF-SCHISTOSOMA-HAEMATOBIUM-BLADDER-PREVENTION, RF-SCLC-BRAIN-METS-EMERGENCY, RF-SCLC-FRAILTY-AGE, RF-SCLC-HIGH-RISK-BIOLOGY, RF-SCLC-INFECTION-SCREENING, RF-SCLC-ORGAN-DYSFUNCTION, RF-SCLC-PARANEOPLASTIC, RF-SCLC-SVC-SYNDROME, RF-SCLERODERMA-LUNG-PREVENTION, RF-SDH-CONFIRMED-CARRIER, RF-SDH-FAMILY-HISTORY-SUSPICION, RF-SJOGREN-MALT-LYMPHOMA-PREVENTION, RF-SMZL-FRAILTY-AGE, RF-SMZL-HIGH-RISK-BIOLOGY, RF-SMZL-INFECTION-SCREENING, RF-SMZL-ORGAN-DYSFUNCTION, RF-SMZL-TRANSFORMATION-PROGRESSION, RF-SOKAL-HIGH, RF-T-ALL-CNS-LEUKEMIA, RF-T-ALL-EMERGENCY-TLS-LEUKOSTASIS, RF-T-ALL-FRAILTY-AGE, RF-T-ALL-HIGH-RISK-BIOLOGY, RF-T-ALL-INFECTION-SCREENING, RF-T-ALL-MEDIASTINAL-AIRWAY, RF-T-ALL-ORGAN-DYSFUNCTION, RF-T-ALL-TRANSFORMATION-PROGRESSION, RF-T-PLL-HIGH-RISK-BIOLOGY, RF-T-PLL-INFECTION-SCREENING, RF-T-PLL-ORGAN-DYSFUNCTION, RF-T-PLL-TRANSFORMATION-PROGRESSION, RF-TCELL-CD30-POSITIVE, RF-THYROID-ANAPLASTIC-FRAILTY-AGE, RF-THYROID-ANAPLASTIC-HIGH-RISK-BIOLOGY, RF-THYROID-ANAPLASTIC-INFECTION-SCREENING, RF-THYROID-ANAPLASTIC-ORGAN-DYSFUNCTION, RF-THYROID-ANAPLASTIC-TRANSFORMATION-PROGRESSION, RF-THYROID-PAPILLARY-FRAILTY-AGE, RF-THYROID-PAPILLARY-HIGH-RISK-BIOLOGY, RF-THYROID-PAPILLARY-INFECTION-SCREENING, RF-THYROID-PAPILLARY-ORGAN-DYSFUNCTION, RF-THYROID-PAPILLARY-TRANSFORMATION-PROGRESSION, RF-UNIVERSAL-AGE-50PLUS-SCREENING-GAP, RF-UNIVERSAL-CURRENT-SMOKER-MULTI-CANCER, RF-UNIVERSAL-ELEVATED-BMI-CANCER-CLUSTER, RF-UNIVERSAL-FIRST-DEGREE-CANCER-FAMILY-ANY, RF-UNIVERSAL-HBV-REACTIVATION-RISK, RF-UNIVERSAL-HEAVY-ALCOHOL-MULTI-CANCER, RF-UNIVERSAL-IMMUNOCOMPROMISED-CANCER-RISK, RF-UNIVERSAL-INFUSION-REACTION-FIRST-CYCLE, RF-UNIVERSAL-OCCUPATIONAL-EXPOSURE-MULTIPLE, RF-UNIVERSAL-PRIOR-CANCER-SECONDARY-RISK, RF-UNIVERSAL-TLS-RISK, RF-UROTHELIAL-EV-CONTRAINDICATED, RF-UROTHELIAL-FRAILTY-AGE, RF-UROTHELIAL-HIGH-RISK-BIOLOGY, RF-UROTHELIAL-INFECTION-SCREENING, RF-UROTHELIAL-ORGAN-DYSFUNCTION, RF-UROTHELIAL-TRANSFORMATION-PROGRESSION, RF-UVEAL-MELANOMA-BAP1-MUT-CANDIDATE, RF-VHL-CONFIRMED-CARRIER, RF-VHL-FAMILY-HISTORY-SUSPICION, RF-WILSONS-DISEASE-HCC-PREVENTION, RF-WM-CXCR4-WHIM-MUTANT, RF-WM-FRAILTY-AGE, RF-WM-HIGH-RISK-BIOLOGY, RF-WM-HYPERVISCOSITY, RF-WM-INFECTION-SCREENING, RF-WM-MYD88-L265P-ACTIONABLE, RF-WM-TRANSFORMATION-PROGRESSION